Moderate drinkers who have a pattern of binge drinking are five times more likely to develop alcohol use disorders than moderate drinkers who do not binge drink.
An immune protein called CSF1 may contribute to feelings of anxiety as a result of alcohol withdrawal for those with alcohol use disorder.
Researchers report a significant increase in deaths related to alcohol use disorder during the COVID-19 pandemic. The steepest increase in mortality was seen in the 25-44 age group.
Gene editing could be a potential new treatment for anxiety and alcohol use disorder in adults who indulged in binge drinking as adolescence.
Researchers reveal the role corticotropin-releasing factor produced by neurons plays in alcohol withdrawal symptoms.
Alcohol use disorder is associated with a significant increase in suicidal thoughts in adults.
Heavy drinkers and those at risk of alcohol use disorder show reduced communication between brain areas associated with social and emotional processing.
Psilocybin can restore mGluR2 levels in the prefrontal cortex, and this leads to a reduced risk of relapse for those with alcohol use disorder.
Researchers have identified 579 genetic loci associated with increased risk of disorders associated with self-regulation disorders including addiction, ADHD, and anti-social behavior.
Men who are intoxicated with alcohol have impairments when it comes to correctly assessing emotional facial cues in others. Researchers speculate the findings may explain why alcohol use is often associated with harmful interpersonal and social interactions, such as aggression and domestic violence.
A new dual-drug therapy for alcohol use disorder appears to be effective and has fewer side effects or complications compared to other medications used to treat AUD.
Blocking hippocampal STAT3 in those with alcohol use disorder may alleviate symptoms of depression associated with withdrawal.
